OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH excess, including congenital adrenal ...

Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T ...

Emmanuella Amara Ofoka, a multidisciplinary scientist with expertise in biotechnology, microbiology, cell biology, and ...

Thymagen peptide has garnered attention within scientific circles due to its hypothesized impact on various biological ...

In recent years, the regulatory role of the gut microbiota in the initiation and progression of colorectal cancer (CRC) has attracted growing attention. Among the key microbial contributors, ...

Researchers in Korea have discovered clues in the brain that affect stress resilience. This is the result of the research ...

Dr Dinesh Pendharkar highlights how CAR T–cell therapy is reshaping cancer care in India by equipping the immune system with ...

NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”. These agents mimic cell surface ...

Interleukin-2 (IL-2) inhibitors are immunosuppressive agents that block the activity of IL-2, a cytokine involved in the activation and proliferation ...

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is characterized by a high rate of metastasis ...

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical ...